Sponsor content
342 result(s) found, displaying 171 to 180
-
Designation or determinationPriority review
-
Prescription medicine registrationActive ingredients: trastuzumab deruxtecan.
-
Prescription medicine registrationActive ingredients: dapagliflozin propanediol monohydrate.
-
Prescription medicine registrationActive ingredients: dapagliflozin propanediol monohydrate.
-
Prescription medicine registrationActive ingredients: budesonide; formoterol (eformoterol) fumarate dihydrate; glycopyrronium bromide (glycopyrrolate).
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BRILINTA ODT ticagrelor 90 mg orodispersible tablet blister pack.
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment Report for Durvalumab
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment Report for Olaparib
-
Australian Public Assessment Report (AusPAR)Forxiga (dapagliflozin) has been approved for the treatment of symptomatic heart failure with reduced ejection fraction, as an adjunct to standard of care therapy, in adults.
-
Prescription medicine registrationActive ingredients: osimertinib mesilate.